Genoptix Means:

  • Unique Services
    • COMPASS (Comprehensive Assessment) for Bone Marrow and Blood
      • Case direction, management, and correlation by one dedicated hematopathologist, who reflexes to all medically necessary tests for a final diagnosis
      • All technologies, as medically necessary, required for diagnosis with one simple requisition check mark
        • Morphology, special stains, and immunohistochemistry
        • Multicolor Flow Cytometry
        • Cytogenetics and/or FISH
        • Molecular testing (quantitative BCR/ABL, MPLW515L/K, quantitative JAK2, T-cell and B-cell Clonality Assessment, IgVH, CEBPA, NPM1, FLT3, cKIT, and quantitative PML-RARA)
      • Immediate phone access for consults with a hematopathologist
      • Summary report correlating all results into a concise, patient-specific diagnosis; click here for a COMPASS sample report
      • A clinically relevant workup that considers treatment and management concerns based on clinical history and prior testing


    • CHART (Comprehensive Hematopathology Assessment and Review Over Time)
      • Cumulative summary report correlating all prior COMPASS findings into a patient-specific diagnosis or management information; click here for a CHART sample report
      • Provides complete clinical picture to effectively:
        • Assess residual disease
        • Determine disease progression
        • Evaluate clonal evolution
        • Monitor response to treatment


  • Unique Workflow
    • One dedicated hematopathologist will direct, review, correlate, and diagnose your patient’s case. Click here for an illustrated diagram of the Genoptix unique workflow.


  • Convenience
    • Centralized laboratory for all sample receipt and processing
    • 6 day/week operations—Monday through Saturday, and 24-hour client service representatives
    • Availability of reports online (eCOMPASS2.0), autoprinting, fax, and/or hard copy
    • One call for any need-800.755.1605-including sample pick-up and physician consults


  • Focus
    • Specialization in bone marrow/blood/lymph nodes for hematologic malignancies and disorders, as well as metastatic solid tumor work-ups
    • Expertise in the most challenging diagnoses (e.g., low grade MDS, bi-lineage leukemia)
    • One of the largest national hematopathology centers in the United States


  • Experience
    • Analysis of thousands of bone marrow and blood samples annually
    • More than 30 full-time hematopathologists, with combined medical experience of over 300 years
    • Hematopathology staff credentials from University of Utah, Stanford, Cleveland Clinic, MD Anderson, Cedars-Sinai, University of Chicago, Harvard, and Yale, among others
    • Internal expert second and third opinions, as needed, with no increase in TAT and at no additional cost
    • Weekly seminars and peer review meetings/trainings


  • Timeliness
    • TAT to meet patient scheduling demands
    • 24-48 hours upon receipt for flow cytometry and morphology
    • Acute cases or unexpected diagnoses reported to physician within 24 hours or less


  • Flexibility
    • All patients billed as "in-network"
    • No patient responsibility, except for deductibles and co-pays as required by law

COMPASSTM is a trademark of Genoptix, Inc.
CHART® is a registered trademark of Genoptix, Inc.

hematology